| Literature DB >> 30565412 |
Lars Klug1, Anja Mähler1, Natalia Rakova1, Knut Mai1,2,3, Jeanette Schulz-Menger1,4,5, Gabriele Rahn1, Andreas Busjahn1, Jens Jordan1, Michael Boschmann1, Friedrich C Luft1.
Abstract
The evidence that physical exercise lowers metabolic and cardiovascular risk is undisputed. Normobaric hypoxia training has been introduced to facilitate the effects of exercise. We tested the hypothesis that hypoxia training augments exercise-related effects. We randomized 23 men with metabolic-syndrome to single-blinded exercise at normoxia (FiO2 21%) or hypoxia (FiO2 15%). Six weeks endurance training on a treadmill, 3 days per week, over 60 min at 60% VO2 max was required. The study included the following: (1) metabolic phenotyping by indirect calorimetry and adipose and muscle tissue microdialysis to gain insight into effects on resting, postprandial, and exercise metabolism, (2) cardiac imaging, and (3) biopsies. Primary endpoint was the change in cardiorespiratory fitness; secondary endpoints were as follows: changes in body weight, waist circumference, blood pressure, cardiac dimensions, and adipose and muscle tissue metabolism and gene expression. Our subjects reduced waist circumference and improved several cardiovascular risk markers including blood pressure. However, these effects were similar in both training groups. Cardiac dimensions were not influenced. We focused on glucose metabolism. After an oral glucose load, adipose tissue metabolism was significantly shifted to a more lipolytic state under hypoxia, whereas muscle metabolism was similar under both conditions. Postprandial energy expenditure was significantly increased under hypoxia, whereas activity energy expenditure was improved under normoxia. Gene expression was not consistently influenced by FiO2 . Adipose tissue triglyceride lipase, leptin, and hypoxia-inducible factor-alpha expression were increased by normoxia but not hypoxia.Entities:
Keywords: Exercise training; hypertension; metabolic syndrome; normobaric hypoxia
Mesh:
Substances:
Year: 2018 PMID: 30565412 PMCID: PMC6299242 DOI: 10.14814/phy2.13949
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Subjects and course of the study.
Anthropometric data before and after training under normoxia (N = 11) or hypoxia (N = 12)
| Normoxia | Hypoxia | |||
|---|---|---|---|---|
| Before | After | Before | After | |
| Age (years) | 57.6 ± 2.2 | 55.0 ± 2.1 |
| |
| Height (m) | 1.79 ± 0.02 | 1.76 ± 0.02 | ||
| Weight (kg) | 108.5 ± 3.0 | 106.2 ± 3.3 | 109.1 ± 5.2 | 107.6 ± 5.3 |
| BMI (kg/m2) | 34.1 ± 0.9 | 33.4 ± 1.1 | 35.5 ± 1.4 | 34.9 ± 1.4 |
| Waist (W, cm) | 117 ± 3 | 115 ± 3 | 121 ± 3 | 119 ± 3 |
| Hip (H, cm)) | 115 ± 2 | 115 ± 2 | 116 ± 3 | 115 ± 3 |
| W/H ratio | 1.02 ± 0.01 | 1.00 ± 0.02 | 1.05 ± 0.02 | 1.03 ± 0.02 |
|
| ||||
| FFM (%) | 69.9 ± 2.3 | 70.0 ± 1.9 | 67.5 ± 1.8 | 68.3 ± 1.6 |
| FM (%) | 30.1 ± 2.3 | 30.0 ± 1.9 | 32.5 ± 1.8 | 31.7 ± 1.6 |
|
| ||||
| FFM (%) | 64.7 ± 1.8 | 64.6 ± 1.9 | 63.7 ± 1.7 | 62.5 ± 2.0 |
| FM (%) | 35.3 ± 1.8 | 35.4 ± 1.9 | 36.3 ± 1.7 | 37.6 ± 2.0 |
| REE (kcal/d) | 1891 ± 99 | 1901 ± 45 | 1935 ± 95 | 1962 ± 98 |
| RER | 0.75 ± 0.01 | 0.78 ± 0.01 | 0.75 ± 0.01 | 0.76 ± 0.01 |
Data are given as Mean ± SE.
FFM, fat‐free mass; FM, fat mass; REE, resting energy expenditure; RER, respiratory exchange ratio (O2/CO2).
P < 0.05 between visits.
Cardiometabolic risk factors before and after exercise training under normoxia (N = 11) or hypoxia (N = 12)
| Normoxia | Hypoxia | |||
|---|---|---|---|---|
| Before | After | Before | After | |
| HR (bpm) | 66 ± 2 | 66 ± 2 | 67 ± 3 | 61 ± 3 |
| SBP (mmHg) | 135 ± 4 | 123 ± 5 | 145 ± 3 | 137 ± 3 |
| DPB (mmHg) | 83 ± 3 | 77 ± 3 | 81 ± 2 | 79 ± 3 |
| Glucose (mmol/L) | 5.9 ± 0.4 | 5.9 ± 0.4 | 6.1 ± 0.5 | 5.9 ± 0.3 |
| Insulin ( | 19 ± 3 | 17 ± 4 | 15 ± 2 | 18 ± 3 |
| HbA1c (%) | 5.9 ± 0.2 | 5.8 ± 0.2 | 5.9 ± 0.3 | 5.7 ± 0.2 |
| TG (mg/dL) | 228 ± 26 | 188 ± 23 | 218 ± 59 | 163 ± 25 |
| HDL (mg/dL) | 43 ± 2 | 41 ± 2 | 52 ± 5 | 47 ± 4 |
| LDL (mg/dL) | 129 ± 14 | 114 ± 10 | 147 ± 14 | 134 ± 14 |
| LDL/HDL | 3.1 ± 0.3 | 3.0 ± 0.3 | 3.0 ± 0.3 | 3.0 ± 0.3 |
Data are given as Mean ± SE.
HR, heart rate; SBP/DBP, systolic/diastolic blood pressure; TG, triglycerides; HDL/LDL, high/low density lipoprotein.
P < 0.05 between visits
P < 0.01 between visits.
Spiroergometry parameter before and after exercise training under normoxia (N = 9) or hypoxia (N = 12)
| Normoxia | Hypoxia | |||
|---|---|---|---|---|
| Before | After | Before | After | |
| Workloadmax (W) | 158 ± 31 | 164 ± 28 | 152 ± 23 | 156 ± 30 |
| HRmax (bpm) | 132 ± 20 | 134 ± 23 | 141 ± 19 | 138 ± 15 |
|
| 2434 ± 593 | 2507 ± 535 | 2318 ± 330 | 2376 ± 421 |
| RERmax | 0.98 ± 0.04 | 0.98 ± 0.04 | 0.99 ± 0.05 | 0.99 ± 0.06 |
| Lactatemax (mmol/L) | 5.54 ± 2.16 | 5.43 ± 1.85 | 5.89 ± 1.65 | 5.40 ± 0.86 |
| Lactate threshold (mmol/L) | 1.60 ± 0.65 | 1.77 ± 0.66 | 1.69 ± 0.37 | 1.72 ± 0.32 |
| WorkloadTraining (W) | 81 ± 19 | 102 ± 28 | 86 ± 19 | 93 ± 17 |
| HRTraining (bpm) | 102 ± 11 | 109 ± 13 | 112 ± 14 | 110 ± 11 |
Data are given as Mean ± SD
HR, heart rate; RER, respiratory exchange ratio (CO2/O2).
P < 0.05 between visits.
Cardio‐MRT data before and after exercise training under normoxia (N = 6) or hypoxia (N = 8)
| Normoxia | Hypoxia | |||
|---|---|---|---|---|
| Before | After | Before | After | |
| EDV (mL) | 158.3 ± 11.5 | 161.1 ± 13.2 | 168.0 ± 31.1 | 171.3 ± 34.1 |
| ESV (mL) | 63.2 ± 9.0 | 62.5 ± 12.2 | 61.2 ± 17.9 | 64.0 ± 19.8 |
| SV (mL) | 95.0 ± 11.7 | 98.6 ± 5.8 | 106.8 ± 16.5 | 107.3 ± 15.5 |
| EF (%) | 60.0 ± 5.6 | 61.5 ± 5.3 | 64.2 ± 5.6 | 63.5 ± 5.2 |
| Myomass (g) | 135.1 ± 19.8 | 138.6 ± 17.3 | 151.2 ± 33.2 | 150.7 ± 32.3 |
| EDV/H (mL/m) | 87.6 ± 5.8 | 83.3 ± 16.1 | 96.3 ± 17.1 | 97.9 ± 18.7 |
| EDV/BSA (mL/m2) | 69.6 ± 4.8 | 68.1 ± 7.9 | 76.4 ± 12.0 | 76.7 ± 13.8 |
| ESV/H (mL/m) | 34.5 ± 6.0 | 32.3 ± 9.0 | 34.1 ± 10.1 | 36.5 ± 11.0 |
| ESV/BSA (mL/m2) | 27.8 ± 4.1 | 26.4 ± 5.7 | 27.7 ± 7.2 | 28.6 ± 8.4 |
| SV/H (mL/m) | 52.6 ± 6.1 | 51.0 ± 9.1 | 61.2 ± 8.8 | 61.4 ± 8.4 |
| SV/BSA (mL/m2) | 41.3 ± 4.6 | 41.7 ± 4.4 | 48.9 ± 6.9 | 48.2 ± 6.2 |
| Myomass/H (g/m) | 74.7 ± 10.1 | 71.4 ± 16.7 | 86.6 ± 18.0 | 86.1 ± 17.4 |
| Myomass/BSA (g/m2) | 59.3 ± 7.8 | 58.7 ± 9.6 | 69.0 ± 15.4 | 67.4 ± 12.5 |
| LVRI | 0.86 ± 0.15 | 0.87 ± 0.13 | 0.91 ± 0.17 | 0.89 ± 0.14 |
Data are given as Mean ± SD
EDV, end‐diastolic volume; ESV, end‐systolic volume; SV, stroke volume; EF, ejection fraction; H, height; BSA, body surface area; LVRI, left ventricular remodeling index.
P < 0.05, hypoxia versus normoxia at corresponding time points.
Relative changes in adipocyte and myocellular mRNA expression of some marker genes after exercise training under either normoxic or hypoxic conditions
| Normoxia | Hypoxia | |
|---|---|---|
| Adipose tissue | ||
| HSL | 4.5 ± 6.8 | 1.0 ± 1.1 |
| PGC1a | 1.2 ± 0.7 | 0.8 ± 0.5 |
| Skeletal muscle | ||
| Akt2 | 1.2 ± 0.5 | 1.2 ± 0.9 |
| CPT1 | 1.3 ± 0.7 | 1.5 ± 0.9 |
| Glut4 | 1.3 ± 0.9 | 1.4 ± 1.2 |
| HIF1a | 1.3 ± 0.6 | 1.0 ± 0.4 |
| MEF2a | 1.1 ± 0.4 | 1.0 ± 0.5 |
| PGC1a | 1.2 ± 0.5 | 1.1 ± 1.2 |
| PGC1b | 1.1 ± 0.2 | 1.0 ± 0.7 |
| PRKAA1 | 1.1 ± 0.3 | 0.9 ± 0.4 |
Data are given as Mean ± SD.
HSL, hormone‐sensitive lipase; PGC 1 a/b, peroxisome proliferator activated receptor gamma coactivator 1 a/b; Akt2, RAC‐beta serine/threonine‐protein kinase/protein kinase B beta; CPT1, carnitine palmitoyl transferase 1; HIF1a, hypoxia‐inducible factor 1 alpha; MEF2a, myocyte enhancer factor 2a; PRKAA1, protein kinase AMP‐activated catalytic subunit alpha 1.
Figure 2Changes in blood glucose and insulin levels after an oral glucose load before and after a moderate 6‐week training under either normobaric normoxic (N = 11) or hypoxic (N = 12) conditions. Data are given as means ± SE.
Figure 3Changes in energy expenditure (absolute and relative) and respiratory exchange ratio (RER) after an oral glucose load (75 g) before and after a moderate 6‐week training under either normobaric normoxic (N = 11) or hypoxic (N = 12) conditions. Data are given as means ± SE.
Figure 4Changes in ethanol (EtOH) ratio and dialysate glucose, lactate and glycerol concentrations in adipose tissue after an oral glucose load before and after a moderate 6‐week training under either normobaric normoxic (N = 11) or hypoxic (N = 12) conditions. Data are given as means ± SE.
Figure 5Changes in ethanol (EtOH) ratio and dialysate glucose, lactate and glycerol concentrations in skeletal muscle after an oral glucose load before and after a moderate 6‐week training under either normobaric normoxic (N = 11) or hypoxic (N = 12) conditions. Data are given as means ± SE.
Figure 6Changes in energy expenditure (EE) and respiratory exchange ratio (RER, CO 2/O2) after a 12 h overnight fast and moderate bicycle exercise over 60 min before and after a moderate 6‐week training under either normobaric normoxic (N = 11) or hypoxic (N = 12) conditions. Data are given as means ± SE.
Figure 7Relative changes in adipose tissue mRNA expression of adipose triglyceride lipase (ATGL), leptin, and hypoxia‐induced factor (HIF) 1alpha and 2alpha before and after a moderate 6‐week training under either normobaric normoxic (N = 8) or hypoxic (N = 11) conditions.